FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to techniques of intensive and respiratory therapy in cardiosurgical interventions, and can be used for treating nosocomial pneumonia in cardiosurgical patients. Method consists in conducting a systemic antibacterial therapy. In addition, inhalations of nitrogen oxide in concentration of 200 ppm are performed for 30 minutes each 3 times day for 7 days from the moment of diagnosis or until resolution of the disease, if resolution occurred earlier.
EFFECT: method enables reducing the length of treatment of nosocomial pneumonia in cardiosurgical patients.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTION OF NOSOCOMIAL PNEUMONIA IN CARDIOSURGICAL PATIENTS | 2023 |
|
RU2817677C1 |
METHOD FOR PNEUMONIA TREATMENT IN PATIENTS WITH CARDIASURGICAL PROFILE IN EARLY POSTOPERATIVE PERIOD WITH ARTIFICIAL LUNG VENTILATION OR WITH INTUBATION | 2016 |
|
RU2638462C1 |
Respiratory therapy method for new coronavirus infection COVID-19 in patients on artificial lung ventilation | 2020 |
|
RU2744550C1 |
METHOD FOR PREVENTION OF ENTERIC-ASSOCIATED COMPLICATIONS IN CARDIOSURGICAL OPERATIONS IN CONDITIONS OF CIRCULATORY ARREST | 2024 |
|
RU2834164C1 |
METHOD FOR THE TREATMENT AND PREVENTION OF RECURRENCE OF NOSOCOMIAL PNEUMONIA | 2021 |
|
RU2794585C2 |
METHOD OF MULTI-ORGAN PROTECTION AT CARDIAC SURGICAL INTERVENTIONS ACCOMPANIED BY CIRCULATORY ARREST | 2018 |
|
RU2681123C1 |
METHOD OF ORGANOPROTECTION IN CASE OF CARDIAC SURGERY INTERFERENCES WITH ARTIFICIAL BLOOD CIRCULATION | 2018 |
|
RU2681124C1 |
METHOD OF PROTECTING KIDNEYS DURING CONDUCTING EXTRACORPOREAL LIFE SUPPORT | 2018 |
|
RU2687010C1 |
METHOD OF RESPIRATORY THERAPY IN NEW CORONAVIRUS INFECTION COVID-19 IN PATIENTS WITH RESPIRATORY FAILURE, WHO ARE ON SPONTANEOUS BREATHING | 2021 |
|
RU2769489C1 |
METHOD FOR LABORATORY DIAGNOSIS OF PNEUMONIA | 2020 |
|
RU2733048C1 |
Authors
Dates
2025-04-07—Published
2024-07-12—Filed